Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo
Public ClinicalTrials.gov record NCT01426269. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® Capsules Compared to Placebo After an Initial 12 Week Treatment Regimen With Oracea® and MetroGel® 1% in Adults With Rosacea
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess relapse, efficacy and safety in subjects with rosacea during long-term treatment with either Oracea® or placebo, after an initial 12-week regimen of Oracea® and MetroGel® 1%.
Study identification
- NCT ID
- NCT01426269
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 235 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2011 (Type not available)
- Primary completion
- Jun 2013 (Actual)
- Completion
- Jun 2013 (Actual)
- Last update posted
- Aug 1, 2022
2011 – 2013
United States locations
- U.S. sites
- 11
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| ATS Clinical Research | Santa Monica | California | 90404 | — |
| Dadeland Dermatology | Coral Gables | Florida | 33134 | — |
| Melissa L. F. Knuckles M.D., P.S.C. | Corbin | Kentucky | 40701 | — |
| Dermatology Specialists Research | Louisville | Kentucky | 40202 | — |
| Melissa L. F. Knuckles M.D., P.S.C. | Richmond | Kentucky | 40475 | — |
| The Maryland Laser, Skin, and Vein Institute, LLC | Hunt Valley | Maryland | 21030 | — |
| Grekin Skin Institute | Warren | Michigan | 48088 | — |
| Hilary Baldwin | Brooklyn | New York | 11201 | — |
| The Center for Dermatology at Linden Oaks | Rochester | New York | 14625 | — |
| Brodell Medical, Inc. | Warren | Ohio | 44483 | — |
| Center for Dermatology and Laser Surgery | Portland | Oregon | 97225 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01426269, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 1, 2022 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01426269 live on ClinicalTrials.gov.